Stem Cells Framework Data Initiative

 

 

Stem cells allow us to study fundamental processes in tissue growth, development, ageing and disease. The next waves of medicine will build on personalised therapies for drug treatments that require an understanding of drug-genetic-tissue interactions. Stem cell programs that can direct the differentiation of cells lead to the assembly of mini-organs in a dish that are already in use for disease screening in Australia, and around the world.

The delineation of Stem Cell populations into tissues and organs from heterogeneous (diverse) populations is a complex and still ill-defined process. Characterisation of the process using multi ‘omics methodologies will provide insights into biology and potential applications of Stem Cells.

This Bioplatforms Australia Framework Data Initiative is led by Dr Christine Wells from the University of Melbourne and will bring together world-class expertise in pluripotent stem cell biology, including stem cell transgenics, imaging, single cell analysis, cell biology, haematopoiesis, as well as genome biology and stem cell bioinformatics.

Scientists from Stem Cells Australia (SCA) will be driving the experimental work proposed for this project. The collaborative network of SCA contains partners from the University of Melbourne, Monash University, University of Queensland, University of New South Wales, Walter and Eliza Hall Institute for Medical Research, Victor Chang Cardiac Research Institute, The Florey Institute of Neuroscience and Mental Health, and CSIRO – Materials Science Division.

For further information please visit the Bioplatforms Australia Metadata Portal: https://data.bioplatforms.com/organization/about/bpa-stemcells

Project contacts:

Christine Wells | T: 03 8344 3795 | wells.c@unimelb.edu.au
Anna Fitzgerald | T: 02 9850 1174 | afitzgerald@bioplatforms.com

Media Articles and Publications

Stem Cells Press Release

Bioplatforms Australia
August 2016
View Article